This is an area where #China excels and likely, leading the planet. The value and future of #humanoid technology for #aiinhealthcare is so misunderstood and underappreciated, IMO. Yes it is his personal feed, but this is the CEO of Insilico Medicine. #RoboticsForAll #aiforhealth

I am planning to propose in the near future. Stay tuned!

#ARDD2024 Kicks off this week! Be sure to catch our team in #Copenhagen.

We’re excited to introduce you to #Alchemistry, the latest groundbreaking addition to our Chemistry42 platform. Imagine harnessing the power of AI to design novel compounds and accelerate your #drugdiscovery process like never before. insilico.com/chemistry42#re…

Zhavoronkov explains that Insilico’s #P3GPT, a large language model (#LLM) engine, can identify promising avenues of research. Read the full piece here: informationweek.com/machine-learni…

Something that I experienced first-hand as a graduate student when I was tasked with writing numerous grants, papers, and reports,” said Kamya. “We developed Science42:#DORA to help eliminate that debilitating barrier to writing #scientificdocuments.” genengnews.com/topics/artific…

Question of the day: Did #generativeAI improve drug discovery? genengnews.com/topics/artific…

Curious to learn more about how #GenAI is transforming the #BioPharma industry across the entire drug discovery and development life cycle from #R&D to #commercial stages? 💊 It's a big week in #NY next week! I invite you to join us after Primary Venture Partners #NYSummit at

Great to have Frank Pun of Insilico Medicine opening our AI and Ageing session, supported by Biotechnology and Biological Sciences Research

ARDD24: Longevity Medicine Track Report Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs) Dr. Evelyne Yehudit Bischof The Scheibye-Knudsen Lab Dominika Wilczok DrPakpilai Thavisin Michael Ringel, JD PhD Nir Barzilai Thomas Rando Jamie Justice XPRIZE Nicole Sirotin, MD David Dodick Andrew Steele linkedin.com/pulse/ardd24-l…

linkedin.com/feed/update/ur…

Hear the latest #TuesdayTalks featuring Alex Zhavoronkov, PhD (aka Aleksandrs Zavoronkovs), part of the We Will Cure series. linkedin.com/posts/curenyc_…

#ARDD2024

New paper alert: Multimodal Transformers and Their Applications in Drug Target Discovery for Aging and Age-Related Diseases . If you want a summary on transformers in aging research and target discovery, here you go! academic.oup.com/biomedgerontol…

The longevity biotechnology industry is deeply thankful to Dr. Michael Ringel of Boston Consulting Group for helping make it more credible and bringing big pharma to the table. BCG is expert in this new and rapidly growing industry. And it is not only about anti-obesity and anti-dementia

With Science42: #DORA, you can effortlessly create professional scientific articles, literature reviews, perspective summaries, case reports, and more insilico.com/science42/dora

news-medical.net/news/20240905/…

linkedin.com/feed/update/ur…

linkedin.com/feed/update/ur…

news-medical.net/news/20240905/… #Chemistry42, a multi-agent reinforcement learning system designed with medicinal chemists in mind, is designed to tackle key challenges in small molecule drug discovery, including novelty, diversity, property prediction, and multi-parametric optimization.